Technology & Science
May 7, 2011
Biotechs Await Ruling on Gene Patents
Companies that develop everything from drugs to biofuels to new crops are on the edge of their seats waiting for a decision in on appeal over patenting genes, including California biotechs who filed amicus briefs in the case.
Daily Journal Staff Writer
Companies that develop everything from drugs to biofuels to new crops are on the edge of their seats waiting on a decision in a key appeal over patenting genes.
Among the entities watching most closely, three California biotechnology companies have submitted amicus briefs in the case, Association for Molecular Pathology, et. al. v. the U.S. Patent and Trademark Office and Myriad Genetics Inc....
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In